Drug Profile
PMK N02RS1
Alternative Names: N-02RS1; PMK-N02RS1Latest Information Update: 06 Apr 2017
Price :
$50
*
At a glance
- Originator PharmaKing
- Class Antibronchitics; Herbal medicines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Bronchitis
Most Recent Events
- 06 Apr 2017 Phase-II development for chronic low-grade respiratory diseases, specifically Bronchitis, is ongoing in South Korea (PO)
- 01 Mar 2016 PharmaKing completes a phase IIb trial for Bronchitis in South Korea (PO) (NCT02637310)
- 01 Dec 2015 PharmaKing initiates a phase IIb trial for Bronchitis in South Korea (PO) (NCT02637310)